Sequence Bio

Sequence Bio is a Biotechnology Research company. Sequence Bio is a company that studies the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from the start. Sequence Bio employs 19 people (+5.6% YoY, +1 person), founded in 2013. Headquartered in St John's, Newfoundland and Labrador, Canada, with presence in United States. Its workforce is distributed across Canada and United States.

About

90% of potential drugs fail, often because they lack the genetic evidence to